Two studies find that an experimental cholesterol-lowering drug is effective when combined with statins and beats another add-on drug when it comes to helping hard-to-treat patients. The drug, ...
Co announced that Schering-Plough K.K., the co's country operation in Japan, has received marketing approval for ZETIA (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results